Prostate removal recovery study using drain fluid test
Part of Cancer, Kidney & urinary clinical trials.
This study looks at a test done on the fluid from your surgical drain after prostate removal. It aims to see if changes in that test over time can help predict how well you recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been treated for prostate cancer with surgery to remove your prostate.
- You did not receive hormone therapy or chemotherapy before your surgery.
- You did not have any urine leakage after surgery (confirmed by a test on the drain fluid).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how levels of PSA in the fluid from a drainage tube after prostate removal may help predict the future course of prostate cancer. It may offer insights into recovery and next steps.
This study looks at changes in a marker called PCA3 in the fluid drained from the surgical site after prostate removal. It aims to help predict recovery and cancer outcomes for prostate cancer patients.
This study looks at swelling caused by lymph fluid buildup after urinary (urologic) surgery that removes lymph nodes. If you’re scheduled for or recently had this type of surgery, this trial may help researchers understand how to prevent or treat this swelling.
This trial studies whether testosterone levels before and around radical prostate surgery affect cancer control and sexual/physical recovery. It may help doctors understand who benefits from testosterone replacement and who should not.
This trial tests a new way to find microscopic cancer cells (minimal residual disease) in the blood after prostate surgery. If successful, it could help doctors decide if additional treatment is needed.
This trial studies prostate cancer cells in the blood (“circulating tumor cells”) while you undergo planned prostate surgery. It may help doctors better understand prostate cancer and how it behaves early, which could guide future treatment decisions.
Hear when a new Prostatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.